COMP <GO>
TACT vs INVE // 10Y YIELD & FRED MACRO BETA
TransAct Technologies Incorporated (NASDAQ) VS. INVE Technologies Inc. (NASDAQ) • 15-METRIC TALLY: TACT 9
— INVE 1
■ METRIC PARITY
LAST: $5.59 (+1.64%) • MKT CAP: $57.7M
macro-sensitivity
—
LAST: $2.68 (-0.37%) • MKT CAP: $65.0M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TACT VS. INVE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TACT | INVE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.60% | 6.10% | +42.50 | TACT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.50% | -35.00% | +24.50 | TACT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 13.11% | -10.32% | +23.43 | TACT | /fcf-yield <GO> |
| Operating Margin | -2.70% | -60.00% | +57.30 | TACT | /operating-margins <GO> |
| Net Profit Margin | -2.40% | -60.00% | +57.60 | TACT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | -19.30% | +38.00 | TACT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 1.07 | +3.30 | TACT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | TACT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.0 | 60.6 | +2.42 | TACT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $57.7M | $65.0M | -$7.2M | INVE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TACT REV | INVE REV | TACT GROSS % | INVE GROSS % | TACT FCF | INVE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $51.5M | $21.5M | 48.6% | 6.1% | $7.6M | -$6.7M |
| FY 2024 | $43.4M | $26.6M | 49.5% | 1.3% | $1.5M | -$15.4M |
| FY 2023 | $72.6M | $43.4M | — | — | $5.5M | $1.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TACT // BETA —
INVE // BETA —